Daniel Patrick discusses the small biotech company journey from an incubator of ideas to the ability to shepherd an R&D asset through its pipeline to achieving commercial success.
Daniel Patrick
Advertisement
Daniel Patrick is a principal consultant at TayganPoint Consulting Group.
Articles by Daniel Patrick
Advertisement
Latest Updated Articles
- What Issues Are Top of Mind for Smaller Biotech and Emerging Biopharma Companies?
Published: August 6th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
WHO Finalizes United States’ Withdrawal from Organization: Report
2
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
3
Janux Therapeutics Enters $850 Million Collaboration and Exclusive License Agreement with Bristol Myers Squibb to Develop Tumor-Activated Therapeutics
4
From Evidence to Access: How Real-World Data Delivers for Patients
5